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Background: Traditionally, interferon-γ (IFN-γ) was regar-
ded as a pro-inflammatory cytokine, however, recent reports 
suggested role of IFN-γ in immune tolerance. In our pre-
vious report, we could induce tolerance to male antigen (HY) 
just by male islet transplantation in wild type C57BL/6 mice 
without any immunological intervention. We tried to inves-
tigate the influence of IFN-γ deficiency on tolerance induc-
tion by male islet transplantation. Methods: To examine the 
immunogenicity of male tissue in the absence of IFN-γ, we 
transplanted male IFN-γ knock-out (KO) skin to female 
IFN-γ KO mice. Next, we analyzed male IFN-γ KO islet to 
streptozotocin-induced diabetic female IFN-γ KO mice. 
And, we checked the functionality of grafted islet by graft re-
moval and insulin staining. Results: As our previous results in 
wild type C57BL/6 mice, female IFN-γ KO mice rejected 
male IFN-γ  KO skin within 29 days, and did not reject male 
IFN-γ KO islet. The maintenance of normal blood glucose 
level was dependent on the presence of grafted male islet. 
And the male islet recipient did not reject 2nd challenge of 
male islet graft also. Conclusion: Deficiency of IFN-γ does 
not have influence on the result of male skin graft and male 
islet transplantation. Conclusively, male islet transplantation 
induced T cell tolerance is not dependent on the presence of 
IFN-γ.
[Immune Network 2011;11(6):358-363]
INTRODUCTION
I t  h a s  b e e n  k n o w n  t h a t  t h e  s k i n  g r a f t  a c r o s s  m i n o r  h i s t o -
compatibility of male antigen (HY) mismatch is normally re-
jected  (1,2).  However,  in  our  previous  report,  islet  trans-
plantation across HY barrier without any immunological ma-
nipulation induced HY antigen specific immunological toler-
ance which prevented the rejection of subsequent skin graft 
i n  C 57 B L/6  m ou se  m od e l (3 ).  In  t ha t t o le ran c e,  i nc re as ed 
Foxp3
+  regulatory  T  cells  (Treg)  mediated  the  tolerance 
induction. To explore the factor that made Treg increase and 
tolerance induction caused by islet transplantation, we started 
subtraction  study  using  knock-out  (KO)  mouse.  Our  first 
c h o i c e  w a s  i n t e r f e r o n - γ (IFN-γ)  KO  mouse. 
  I F N - γ was  regarded  traditionally  as  a  pro-inflammatory 
cytokine. However its protective role in Th-1 cell-associated 
autoimmune diseases has recently been reported (4). For in-
stance, ablation of IFN-γ resulted in aggravation of murine 
autoimmune disease, collagen-induced arthritis (CIA), indicat-
ing that endogenous IFN-γ inhibits important inflammatory 
pathway (5,6). The protective effects of endogenous IFN-γ 
also have been reported in other autoimmune models such 
as  experimental  autoimmune  encephalomyelitis  (EAE),  ex-
perimental autoimmune uveitis (EAU), autoimmune nephritis, 
and  myocarditis  (7-13). 
    In  Treg  development,  activation  of  signal  transducer  and 
activator  of  transcription-1  (STAT-1)  seems  to  have  a  role 
(14). This suggests that cytokine, such as IFN-γ, that activate 
S T A T - 1  h a v e  a  r o l e  i n  T r e g  d evelopment  (4).  Wang  et  al. 
(15) have reported that in vitro treatment of CD4
＋CD25
− T 
cells  with  IFN-γ l e a d s  t o  t h e i r  c o n v e r s i o n  t o  F o x p 3
+ T r e g  
cells. And, copolymer-I induced in vitro Treg conversion was 
dependent  on  IFN-γ (16).  In  addition,  Feng  et  al.(17)  re-Male Islet Transplantation in IFN-γ KO Mice
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ported that ex vivo IFN-γ conditioning of CD4
+ T cells with 
immature dendritic cells resulted in the Treg conversion, and 
these  induced  Treg  cells  could  prevent  allograft  rejection. 
Another study in mice showed that IFN-γ expression in Treg 
cells is transiently up-regulated after alloantigen exposure in 
vivo  and  is  important  for  their  regulatory  function  (18).  In 
another study, in vitro activated Treg cells have shown to pro-
duce IFN-γ and to also stimulate dendritic cells to produce 
indoleamine 2,3-dioxygenase (IDO) (19). This enzyme con-
verts the essential amino acid tryptophan into N-formylkynur-
enine (20). By depleting tryptophan, IDO exerts the capacity 
to inhibit T-cell  response. Recent evidence  suggests an  im-
p o r t a n t  r o l e  o f  I D O  i n  t h e  i n d u c t i o n  o f  t o l e r a n c e  ( 2 1 ) .  
    Considering roles of IFN-γ in self-tolerance and Treg de-
velopment, we speculated that deficiency of IFN-γ might re-
sult  in  the  failure  of  tolerance  induction  in  our  male  islet 
transplantation model. We examined immunogenicity of male 
skin in IFN-γ KO mice, and transplanted male islets to IFN-γ 
KO  mice.  By  these  experiments,  we  confirmed  the  role  of 
IFN-γ in  tolerance  induction  by  male  islet  transplantation. 
MATERIALS AND METHODS
Mice
C57BL/6-Ifng
tm1Ts(IFN-γ knock-out) mice were purchased from 
The Jackson Laboratory (Bar Harbor, ME, USA). All IFN-γ KO 
mice used in this study were genotyped for IFN-γ. PCR was 
done with primers and cycling conditions recommended by 
The Jackson Laboratory. The normal endogenous gene was 
detected  with  forward  primer  IMR126  (5’-AGA  AG  T  AAG 
TGG AAG GGC CCA GAA G-3’) and reverse primer IMR127 
(5’-AGG GAA ACT GGG AGA GGA GAA ATA T-3’). The mu-
tant  (knock-out)  IFN-γ was  detected  with  forward  primer 
IMR128 (5’-TCA GCG CAG GGG CGC CCG GTT CTT T-3’) 
and reverse primer IMR129 (5’-ATC GAC AAG ACC GGC TTC 
CAT CCG A-3’). Endogenous IFN-γ resulted in a 220-bp PCR 
product and mutant IFN-γ resulted in a 375-bp PCR product. 
Mice  were  bred  and  housed  in  a  specific  pathogen-free 
facility. Animal studies were conducted under protocols ap-
proved by Seoul National University Institutional Animal Care 
and  Use  Committee. 
Induction of diabetes mellitus and blood glucose 
monitoring
To  induce  diabetes  mellitus,  mice  were  injected  intra-
peritoneally with 125 mg/kg streptozotocin (Sigma, St. Louis, 
MO,  USA)  in  two  consecutive  days.  After  the  injections, 
non-fasting blood glucose levels were monitored using a gluc-
o m e t e r ,  O n e T o u c h  U l t r a  ( L i f e S c a n  I n c . ,  M i l p i t a s ,  C A ,  U S A )  
from blood obtained by tail snipping. Mice with two consec-
utive non-fasting blood glucose levels higher than 250 mg/dl 
were considered as hyperglycemic mice. Hyperglycemic mice 
were  selected  for  the  islet  transplantation. 
Isolation and transplantation of pancreatic islets
Sacrificed donor mice’s pancreases were injected with Hanks 
balanced salt solution containing 0.5 mg/ml of Collagenage 
P (Roche, Mannheim, Germany) via pancreatic duct. Inflated 
pancreases were excised and incubated in a 37
oC water bath 
for 20 minutes. Digested pancreases were filtered through a 
sieve and washed. Then, islets were purified from digests us-
ing Euro-Ficoll gradients. Obtained islets were re-suspended 
with RPMI 1640 medium (Invitrogen, Carlsbad, CA, USA) sup-
plemented with 10% fetal bovine serum, 2 mM L-glutamine, 
50μg/ml gentamycin, 100μM non-essential amino acids (all 
purchased  from  Invitrogen).  After  overnight  culture,  islets 
were used for the transplantation. Recipient mice were anes-
thetized with Isoflurane. Then, the left kidney was exposed 
and 250∼300 islet equivalent number (IEQ) islets were deliv-
ered  beneath  the  renal  capsule. 
Skin grafting
Full-thickness  tail  skins  obtained  from  donors  were  trans-
planted to the anesthetized recipient mice’s graft beds on the 
left  flank  and  covered  with  Vaseline  gauze  and  Band-Aid 
(Johnson&Johnson, New Brunswick, NJ, USA). Bandages we-
re removed after 7 days, and grafts were observed every 2 
to 3 days for 3 week, and weekly thereafter. The graft was 
s c o r e d  a s  r e j e c t e d  w h e n  l e s s  t h a n  1 0 %  o f  v i a b l e  t i s s u e  r e -
mained  and  visible  inflammation  ended. 
Nephrectomy & histological analysis
Islet recipient’s left kidney was removed under the anesthesia 
to confirm the graft function and to analyze graft histology. 
Removed  kidney  was  frozen  embedded  in  optimal  cutting 
temperature (OCT) compound (Sakura Finetek, Torrance, CA, 
USA). 5μm frozen section was done using Leica CM1850 cry-
ocut  microtome  (Leica,  Wetzlar,  Germany).  Acetone-fixated 
sections  were  stained  with  the  hematoxylin  and  eosin.  For 
insulin staining, sections were treated with guinea pig anti-in-
sulin antibody (Dako Cytomation, Glostrup, Denmark) for 1 
hr at room temperature. After wash with PBS, sections were Male Islet Transplantation in IFN-γ KO Mice
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Figure 1. Male skin rejection in interferon-γ knock-out mice. Full-thickness tail skins obtained from male interferon-γ
knock-out (IFN-γ KO) mice were transplanted to female IFN-γ KO mice (n=3). (A) Percent survival of the transplanted male 
skins is depicted. All recipients rejected male skin within 29 days. Mean survival time was 28 days. (B) One representative 
recipient’s photos of grafted skins are arrayed in serial order. Days after skin graft (8, 21, 25, 28) are marked on the upper-left
corners of each photos. The left grafted skin on the photo is female skin and the right one is male skin. New black hair 
growth on upper part of female skin can be seen. On the other hand, male skin had inflammation and disappeared and black 
hairs on lower part also disappeared. 
treated  with  Alexa  Fluor  555-conjuated  anti-guinea  pig  IgG 
antibody  (Invitrogen)  for  1  hr  at  room  temperature. 
Fluorescence  microscopy  was  performed  using  Carl  Zeiss 
Axio Imager A1 (Carl Zeiss, Jena, Germany). Images were an-
a l y z e d  u s i n g  A x i o V i s i o n  s o f t w a r e  ( C a r l  Z e i s s ) .
RESULTS
Rejection of male skin in interferon-γ  knock-out 
model
In  our  previous  study,  wild  type  C57BL/6  female  mice  re-
jected male skin because of the minor antigen (HY) disparity 
(3). To test whether the absence of interferon-γ (IFN-γ) has 
an  influence  on  the  immunogenicity  of  male  skin,  we  ob-
tained  skin  from  male  IFN-γ knock-out  (KO)  mouse  and 
transplanted it to female IFN-γ KO mice. Female recipients 
r e j e c t e d  m a l e  s k i n  w i t h i n  2 9  d a y s  ( F i g .  1 A ) .  O n  t h e  o t h e r  
hand, the recipients successfully accepted co-transplanted fe-
male skin. We could observe new hair growth of grafted fe-
male skin (Fig. 1B). Therefore, non-acceptance of male skin 
was  not  technical  failure  but  rejection. 
Acceptance of male islet and exclusion of endo-
genous islet regeneration
Wild type C57BL/6 female mice did not reject male islet and 
accepted subsequently grafted male skin (3). To test whether 
the absence of IFN-γ has an influence on the tolerance in-
duction  by  male  islet  transplantation,  we  performed  same 
male islet transplantation in the IFN-γ KO model. Islets were 
obtained from male IFN-γ KO mice, and transplanted to the 
left  kidney  subcapsular  area  of  streptozotocin-induced  dia-
betic female IFN-γ KO mice. Male islet transplantation nor-
malized high blood glucose level of recipients, and the recipi-
e n t s  d i d  n o t  r e j e c t  m a l e  i s l e t  f o r  ＞42  days  (Fig.  2A). 
  To rule out the possibility of recipient’s endogenous islet 
regeneration, we removed transplanted male islet in the left 
kidney  by  nephrectomy.  Three  days  after  the  removal  of 
transplanted  islet,  recipient  returned  to  the  hyperglycemic Male Islet Transplantation in IFN-γ KO Mice
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Figure 2. Male islet transplantation in IFN-γ knock-out mice. Female 
IFN-γ KO mice were rendered diabetic by 2 times of 125 mg/kg 
streptozotocin intraperitoneal injection. Non-fasting blood glucose 
levels were monitored. Male IFN-γ KO islet transplantations were 
operated to the diabetic recipients. Blood glucose levels (mg/dl) 
during the transplantation period are depicted. Each line and points 
indicates individual recipients. (A) Male islet transplantation norma-
lized hyperglycemia of recipients. Recipients maintained normal 
blood glucose levels for ＞42 days (n=3). Arrow indicates the time 
point of male islet transplantation. (B) After the male islet trans-
plantation to recipient’s left kidney, grafted islet was removed by 
nephrectomy. After the re-surge of blood glucose level, 2nd male islet 
transplantation was done and normalized the hyperglycemia again. 
Arrows indicates the time points of 1st male islet transplantation, 
nephrectomy and re-transplantation, respectively. 
Figure 3. Histological analysis of islet graft. Removed kidney containing grafted islet of recipient in Fig. 3B was frozen-sectioned as 5μm 
thickness and acetone-fixated. (A) H&E staining was done to the section. Rectangular area indicates islet region. (B) Insulin staining was done 
with primary guinea pig anti-insulin antibody and secondary Alexa Fluor 555-conjugated anti-guinea pig IgG antibody, subsequently. Red spots
indicate plenty of stained insulin in islet region. Blue spots are nuclei of cells resulted by DAPI staining. (C) As a control of ‘(B)’, secondary 
antibody staining without primary antibody did not result in non-specific red spots. Magnifications are ×100.
state (Fig. 2B). Therefore, the maintenance of normal blood 
glucose  level  was  not  because o f  t h e  e n d o g e n o u s  i s l e t  r e -
generation,  but  was  dependent  on  the  presence  of  trans-
planted male islet. To re-normalize the blood glucose level, 
and  to  check  the  recipient’s  response  to  2nd  antigen  chal-
lenge,  we  again  transplanted  male  IFN-γ KO  islets  to  the 
recipient. 2nd islet transplantation promptly re-normalized the 
hyperglycemia,  and  the  recipient  maintained  normal  blood 
glucose level for ＞32 days (Fig. 2B). Because recipient did 
not  reject  2nd  male  islet,  we  could  conclude  that  non-re-
jection of 1st male islet was not just adaptation, and 1st male 
islet transplantation did not provoked immunological memory 
to  male  antigen. 
Presence of insulin in grafted islet
To confirm whether the grafted islets were functioning, we 
analyzed the insulin secretion by grafted islet using the insulin 
staining of the graft site. Removed kidney containing grafted 
islet of recipient in Fig. 2B was frozen-sectioned and stained 
with hematoxylin & eosin to identify the position of graft site 
(Fig. 3A). Insulin staining was also conducted on the serial 
section.  We  could  detect  plenty  of  insulin-specific  spots  in 
islet region (Fig. 3B). Indicating that grafted islets were ac-
tively secreting insulin. As a control staining, only secondary 
A l e x a  F l u o r  5 5 5 - c o n j u g a t e d  a n t i - g u i n e a  p i g  I g G  a n t i b o d y  
staining  without  primary  anti-insulin  antibody  staining,  did 
not  produced  any  positive  signal  (Fig.  3C).  Therefore,  we Male Islet Transplantation in IFN-γ KO Mice
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could exclude the possibility of non-specific secondary anti-
body  binding  in  Fig.  3B.
DISCUSSION
Role of IFN-γ in self tolerance was occasionally reported in 
a u t o i m m u n e  d i s e a s e  m o d e l s .  H o w e v e r  i t s  r o l e  i n  t r a n s -
plantation  tolerance  is  not  yet  reported.  As  both  the  auto-
immune disease studied and the graft rejection are mediated 
by  Th1  dependent  immune  responses.  We  speculated  that 
IFN-γ could  have  a  role  in  transplantation  tolerance,  too. 
Our male islet transplantation model is unique in that trans-
plantation of a graft without any immunological intervention 
induced antigen specific T cell tolerance. Therefore, we tried 
to check the role of IFN-γ in transplantation tolerance using 
our  male  islet  transplantation  model. 
  I F N - γ has been known to play a very important role in 
graft  rejection  (22),  we  first  tested  whether  the  absence  of 
IFN-γ  in  the  IFN-γ  K O  m o u s e  c o u l d  a f f e c t  t h e  c o n -
sequences of skin and islet transplantation across HY barrier. 
Despite the absence of IFN-γ, female IFN-γ KO mice re-
jected male IFN-γ KO skin and accepted male IFN-γ KO 
islet  as  was  observed  in  the  previous  results  in  wild  type 
C57BL/6  model. 
    Although results of male skin and islet transplantation were 
the same  as those  in WT  mice,  the fate of  male skin  graft 
i n  t h e  r e c i p i e n t  h a r b o r i n g  p r i o r  m a l e  i s l e t  g r a f t  s h o u l d  b e  
checked to confirm the induction of tolerance. However, 2nd 
islet transplantation result indirectly suggests the possibility of 
tolerance induction. If the 1st islet transplantation provoked 
normal  immune  response  to male  antigen,  there  should  be 
accelerated immune response by the induction of immuno-
logical memory. However, the recipient accepted 2nd chal-
lenge of male islet graft indicating the recipient got tolerized 
to  male  antigen  of  HY.     
    Our investigation on the role of IFN-γ in this study could 
not  be  generalized  to  transplantation  tolerance.  To  induce 
transplantation  tolerance,  many  investigators  used  co-stim-
ulatory blockade or co-receptor blockade regimens (23-27). 
However  our  male  islet  transplantation  induced  tolerance 
without  any  immunological  manipulation.  Although  our 
method  also  induced  transplantation  tolerance,  this  unique 
trait  distinguished  our  method  from  other  conventional 
methods. So, it is hard to say that our model is a representa-
tive of general tolerance induction model. Therefore, further 
investigations are required to confirm the role of IFN-γ in 
transplantation  tolerance. 
    As an effort to delineate the underlying mechanisms of im-
mune tolerance induced by the male islet transplantation, we 
checked  the  possible  involvement  of  IFN-γ.  The  achieve-
ment of immunological tolerance across HY barrier in IFN-γ 
KO mouse suggests that IFN-γ would not be the key factor 
for  the  islet  transplantation  mediated  tolerance  induction. 
Further study should be needed to see if other factors known 
to be required for tolerance induction, such as TGF-β (28), 
PD-L1  (29)  would  be  involved  in  the  process  of  tolerance 
induction.
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